Quick Answer
Traws Pharma, Inc. reported Total Revenue of $226.0 thousand for the year ending 2024.
- Traws Pharma, Inc. showed an increase of +0.0% in Total Revenue from 2023 to 2024.
- This data is from Traws Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2011 to 2024 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $198.0 thousand | Q2 2012: $220.0 thousand | Q3 2012: $42.80 million | Q4 2012: $2.97 million | Q1 2013: $1.12 million | Q2 2013: $591.0 thousand | Q3 2013: $1.12 million | Q4 2013: $1.93 million | Q1 2014: $447.0 thousand | Q2 2014: $125.0 thousand | Q3 2014: $114.0 thousand | Q4 2014: $114.0 thousand | Q1 2015: $114.0 thousand | Q2 2015: $123.0 thousand | Q3 2015: $1.62 million | Q1 2016: $1.47 million | Q2 2016: $2.25 million | Q3 2016: $1.65 million | Q1 2017: $210.0 thousand | Q2 2017: $324.0 thousand | Q3 2017: $110.0 thousand | Q1 2018: $564.0 thousand | Q2 2018: $485.0 thousand | Q3 2018: $120.0 thousand | Q1 2019: $68.0 thousand | Q2 2019: $2.02 million | Q3 2019: $63.0 thousand | Q1 2020: $52.0 thousand | Q2 2020: $56.0 thousand | Q3 2020: $66.0 thousand | Q1 2021: $56.0 thousand | Q2 2021: $57.0 thousand | Q3 2021: $57.0 thousand | Q1 2022: $56.0 thousand | Q2 2022: $57.0 thousand | Q3 2022: $57.0 thousand | Q1 2023: $56.0 thousand | Q2 2023: $57.0 thousand | Q3 2023: $57.0 thousand | Q1 2024: $56.0 thousand | Q2 2024: $57.0 thousand | Q3 2024: $57.0 thousand | Q1 2025: $57.0 thousand | Q2 2025: $2.73 million.
- Over the full 14 years of available data (2011 to 2024), Traws Pharma, Inc.'s Total Revenue has declined by 84.8%.
- Historical annual values: Fiscal year 2024: $226.0 thousand | Fiscal year 2023: $226.0 thousand | Fiscal year 2022: $226.0 thousand | Fiscal year 2021: $226.0 thousand | Fiscal year 2020: $231.0 thousand | Fiscal year 2019: $2.18 million | Fiscal year 2018: $1.23 million | Fiscal year 2017: $787.0 thousand | Fiscal year 2016: $5.55 million | Fiscal year 2015: $11.46 million | Fiscal year 2014: $800.0 thousand | Fiscal year 2013: $4.75 million | Fiscal year 2012: $46.19 million | Fiscal year 2011: $1.49 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: